After turbulent years, Teva CEO Schultz forecasts stability - The Jerusalem Post
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Who's Kare Schultz, (NYSE:TEVA) New CEO In Charge Of Teva? | Benzinga
Teva made smart decision to move to us: Allergan CEO
CEO of Israeli drug maker Teva Pharmaceutical Industries Ltd.'s... News Photo - Getty Images
Teva CEO Erez Vigodman Steps Down | CHEManager
Teva finally announces successful CEO appointment | Pharmafile
Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Teva CEO to Step Down, Be Replaced by Chairman | Fortune
Teva Appoints John Nason President, TAPI and Biologics Operations | Business Wire
Teva to Sell $6.75 Billion in Stock to Buy Allergan Unit, Rimsa - Jewish Business News
Teva CEO on decimated share price: "It's rational enough from a market point of view"
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | FiercePharma
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Teva CEO reportedly wanted to stay in his job | The Times of Israel
Shlomo Yanai, incoming president and CEO (L), and Israel Makov, outgoing president and CEO of Teva Pharmaceutical Industries, Ltd., take part in the opening bell ceremonies at the NASDAQ in New York
Teva sees higher margins, lower debt from restructuring | Financial Times
With 3K-plus Teva layoffs slated in Israel and labor protests brewing, top exec steps aside | FiercePharma
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharmaceuticals - Wikipedia
Teva CEO tells PM no bending on mass redundancy plan
Erez Vigodman steps down as Teva CEO
Teva Pharmaceutical Industries names a new CEO
Teva snags new CEO from Lundbeck
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Teva Pharma CEO: We see a stable U.S. market place for our generics - The Global Herald
